GE Healthcare to Develop Molecular Imaging Platform in Alsace, France

Alsace BioValley announced on September 9 that it has signed a partnership agreement with GE Healthcare to carry out a feasibility study for setting up a technology platform in different fields of molecular imaging. The platform will focus on research and the translational medicine and will be accessible to the region’s scientists as well as to industry partnerships.

This partnership between the Alsace BioValley Competitivity Pole and GE Healthcare aims to pool the partners’ know-how to boost further the growing dynamic for development in the region’s life sciences as well as to provide an instrument that will be indispensable to the development of tools for tomorrow’s medicine.

GE Healthcare will share its knowledge of the various imaging solutions and the different types of platform currently in operation in academia and industry.

The Alsace BioValley Competitivity Pole will ensure that the project will be tightly integrated with leading players in the area so that the tools that are available meet the needs of all concerned and contribute to the development of the Alsace region.

“We chose Alsace as a partner because it has a unique international position in the field of science and technology applied to research and biomedical development,” said Dominique Blanc, General Manager France of GE Healthcare. “Research in Alsace, both basic and applied, from biology to clinical, from chemistry to genetics has earned a worldwide reputation and is an excellent fit for the level of excellence that GE Healthcare looks for in its projects.”

“Signing a partnership agreement with a company as prestigious as GE Healthcare guarantees that Alsace BioValley will be able to create a molecular imaging platform that will be unique in France and an indispensable tool to drive the dynamic of research and translational medicine in Alsace,” said Nicolas Carboni, managing director of Alsace BioValley. “Setting up this type of platform which can model human and animal cells in different ways, will be yet another facility to attract talent and investment to our region.”

Tags: France, GE Healthcare